Macranthoin G exhibits significant anti-inflammatory and neuroprotective properties, making it a compound of interest in the development of therapeutics for neurodegenerative diseases such as Alzheimer’s and Parkinson’s. It has demonstrated the ability to inhibit key pro-inflammatory mediators, including NF-κB and COX-2, in cellular models, suggesting potential use in managing chronic inflammation. Additionally, studies indicate that Macranthoin G can cross the blood-brain barrier effectively, enhancing its suitability for central nervous system-targeted treatments. Its antioxidant activity further supports its role in reducing oxidative stress, a major contributor to neuronal damage. Research is ongoing to explore its efficacy in preclinical models of brain injury and cognitive disorders.